Products aim to address the translation gap and accelerate research and drug discovery for neurodegenerative disease.
29.09.2022Products aim to address the translation gap and accelerate research and drug discovery for neurodegenerative disease.
Products aim to address the translation gap and accelerate research and drug discovery for neurodegenerative disease.
29.09.2022Products aim to address the translation gap and accelerate research and drug discovery for neurodegenerative disease.
bit.bio received a bronze award for its participation in the Green Impact awards for sustainability.
26.09.2022bit.bio’s Founder and CEO Dr Mark Kotter on creating every cell type and kickstarting a cell therapy revolution.
01.09.2022bit.bio is supporting the iGEM team from University of Cambridge in the iGEM synbio competition.
22.08.2022In this Financial Times piece our CEO is reflecting on raising concerns about the lab spaces for rent within science clusters.
04.08.2022This piece covers how bit.bio's technology is also used by Meatable for their cultured meat products.
03.08.2022bit.bio CEO and founder welcomes Meatable's cultured meat sausage, powered by opti-ox.
21.07.2022Dr Farah Patell-Socha and Furqan Iqbal interviewed in the latest issue of Technology Networks.
18.07.2022VP of Research Products Dr Farah Patell-Socha discusses more accurate cell models in neurodegeneration.
14.07.2022